GlassScriptPhysician profile
Melissa A Dercks
NPI 1710202577
$2,216.98
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $826 · 2022: $573 · 2023: $737 · 2024: $79.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $772.34 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $510.57 | 2021-2023 | |
| Lundbeck LLC | $229.49 | 2022-2024 | Vyepti |
| Abbvie INC. | $223.54 | 2021-2023 | |
| Allergan, INC. | $173.54 | 2021-2022 | |
| Livanova USA, INC. | $151.77 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Medtronic, INC. | $134.54 | 2022-2023 | Percept PC Brainsense |
| Emd Serono, INC. | $76.03 | 2022-2023 | Mavenclad |
| Merz Pharmaceuticals, LLC | $74.87 | 2021-2023 | Xeomin |
| Biogen, INC. | $63.49 | 2021-2023 | Vumerity, Tysabri |
| Neurelis, INC. | $63.07 | 2021 | |
| Argenx US, INC. | $49.38 | 2023 | Vyvgart, Vyvgart Hytrulo |
| Teva Pharmaceuticals USA, INC. | $48.01 | 2021-2023 | Austedo Xr |
| Genentech USA, INC. | $41.07 | 2021-2023 | Ocrevus, Enspryng |
| Boston Scientific Corporation | $39.04 | 2023 | Contour |
| Neurocrine Biosciences, INC. | $36.12 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $28.68 | 2022 | |
| Celgene Corporation | $27.88 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $24.58 | 2021 | |
| Ge Healthcare | $22.20 | 2022 | |
| Lilly USA, LLC | $21.86 | 2023 | Emgality, Reyvow |
| Banner Life Sciences, LLC | $21.66 | 2022 | |
| Piramal Critical Care | $21.36 | 2023 | |
| Tg Therapeutics, INC. | $19.96 | 2023 | |
| Ucb, INC. | $19.14 | 2022 | |
| Pfizer INC. | $17.81 | 2023 | |
| Horizon Therapeutics Plc | $17.01 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.06 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.44 | 2022 | |
| Supernus Pharmaceuticals, INC. | $15.38 | 2021 | |
| Sk Life Science, INC. | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Dercks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.